204 related articles for article (PubMed ID: 35535819)
61. P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3.
Feng W; Yang X; Wang L; Wang R; Yang F; Wang H; Liu X; Ren Q; Zhang Y; Zhu X; Zheng G
Haematologica; 2021 May; 106(5):1278-1289. PubMed ID: 32165482
[TBL] [Abstract][Full Text] [Related]
62. Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.
Schwieger M; Schüler A; Forster M; Engelmann A; Arnold MA; Delwel R; Valk PJ; Löhler J; Slany RK; Olson EN; Stocking C
Blood; 2009 Sep; 114(12):2476-88. PubMed ID: 19584403
[TBL] [Abstract][Full Text] [Related]
63. MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
Prange KHM; Mandoli A; Kuznetsova T; Wang SY; Sotoca AM; Marneth AE; van der Reijden BA; Stunnenberg HG; Martens JHA
Oncogene; 2017 Jun; 36(23):3346-3356. PubMed ID: 28114278
[TBL] [Abstract][Full Text] [Related]
64. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
Chen Y; Ernst P
Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
[TBL] [Abstract][Full Text] [Related]
65. Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation.
Barone C; Orsenigo R; Cazzola A; D'Errico E; Patelli A; Quattrini G; Vergani B; Bombelli S; De Marco S; D'Orlando C; Bianchi C; Leone BE; Meneveri R; Biondi A; Cazzaniga G; Rabbitts TH; Brunelli S; Azzoni E
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509285
[TBL] [Abstract][Full Text] [Related]
66. La-related protein 4B maintains murine MLL-AF9 leukemia stem cell self-renewal by regulating cell cycle progression.
Zhang Y; Peng L; Hu T; Wan Y; Ren Y; Zhang J; Wang X; Zhou Y; Yuan W; Wang Q; Cheng T; Zhu X
Exp Hematol; 2015 Apr; 43(4):309-18.e2. PubMed ID: 25534202
[TBL] [Abstract][Full Text] [Related]
67. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
[TBL] [Abstract][Full Text] [Related]
68. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
Jamalpour M; Bergquist E; Welsh M
Exp Cell Res; 2020 Dec; 397(2):112368. PubMed ID: 33220260
[TBL] [Abstract][Full Text] [Related]
69. Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia.
Xie X; Zhang W; Zhou X; Xu B; Wang H; Qiu Y; Hu Y; Guo B; Ye Z; Hu L; Zhang H; Li Y; Bai X
Oncogene; 2023 Dec; 42(50):3657-3669. PubMed ID: 37872214
[TBL] [Abstract][Full Text] [Related]
70. Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.
Placke T; Faber K; Nonami A; Putwain SL; Salih HR; Heidel FH; Krämer A; Root DE; Barbie DA; Krivtsov AV; Armstrong SA; Hahn WC; Huntly BJ; Sykes SM; Milsom MD; Scholl C; Fröhling S
Blood; 2014 Jul; 124(1):13-23. PubMed ID: 24764564
[TBL] [Abstract][Full Text] [Related]
71. Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia.
Ye M; Zhang H; Yang H; Koche R; Staber PB; Cusan M; Levantini E; Welner RS; Bach CS; Zhang J; Krivtsov AV; Armstrong SA; Tenen DG
Cell Stem Cell; 2015 Nov; 17(5):611-23. PubMed ID: 26412561
[TBL] [Abstract][Full Text] [Related]
72. Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.
Chen W; Kumar AR; Hudson WA; Li Q; Wu B; Staggs RA; Lund EA; Sam TN; Kersey JH
Cancer Cell; 2008 May; 13(5):432-40. PubMed ID: 18455126
[TBL] [Abstract][Full Text] [Related]
73. Relationships between AML1-ETO and MLL-AF9 fusion gene expressions and hematological parameters in acute myeloid leukemia.
Muddathir ARM; Hamid TAM; Mohamed Elamin E; Khabour OF
Gulf J Oncolog; 2020 Sep; 1(34):65-69. PubMed ID: 33431365
[TBL] [Abstract][Full Text] [Related]
74. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
[TBL] [Abstract][Full Text] [Related]
75. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
[TBL] [Abstract][Full Text] [Related]
76. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML
Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707
[TBL] [Abstract][Full Text] [Related]
77. Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquine.
Chen X; Clark J; Wunderlich M; Fan C; Davis A; Chen S; Guan JL; Mulloy JC; Kumar A; Zheng Y
Autophagy; 2017 May; 13(5):955-966. PubMed ID: 28282266
[TBL] [Abstract][Full Text] [Related]
78. Krüppel-like factor 4 promotes survival and expansion in acute myeloid leukemia cells.
Lewis AH; Bridges CS; Punia VS; Cooper AFJ; Puppi M; Lacorazza HD
Oncotarget; 2021 Feb; 12(4):255-267. PubMed ID: 33659038
[TBL] [Abstract][Full Text] [Related]
79. C-terminal BRE inhibits cellular proliferation and increases sensitivity to chemotherapeutic drugs of MLL-AF9 acute myeloid leukemia cells.
Pun CC; Lee KK; Chui YL
Leuk Lymphoma; 2019 Dec; 60(12):3011-3019. PubMed ID: 31111759
[TBL] [Abstract][Full Text] [Related]
80. Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
Cui P; Zhang Y; Cui M; Li Z; Ma G; Wang R; Wang N; Huang S; Gao J
Leuk Res; 2018 Feb; 65():49-54. PubMed ID: 29306107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]